InBrain Neuroelectronics today announced $16.8 million in Series A funding for its neuroelectronic system designed to treat epilepsy and Parkinson’s disease.
The investment in the Barcelona-based company was co-led by Asabys Partners and Alta Life Sciences, and joined by Vsquared Ventures and TruVenturo GmbH. The Spanish Ministry of Science’s CDTI also participated, as did the Institut Català de Finances’ ICF Venture Tech II fund, which provided a follow-on investment.
Get the full story on our sister site, Medical Design & Outsourcing.